tiprankstipranks
Trending News
More News >
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990)
:6990
Hong Kong Market
Advertisement

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Dividend Date & History

Compare
1 Followers
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.08 (6.2%)
$111.80B
12.86
+21.50%
4 Buy
5 Hold
2 Sell
Hold
$1.11 (3.84%)
$211.58B
16.87
+34.42%
15 Buy
4 Hold
0 Sell
Strong Buy
$0.65 (16.97%)
$493.25M
-0.33
-62.60%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.7 (2.62%)
$231.51B
40.31
+25.82%
7 Buy
5 Hold
1 Sell
Moderate Buy
$6.76 (4.39%)
$314.60B
19.83
+9.76%
10 Buy
5 Hold
0 Sell
Moderate Buy
$3.835 (3.26%)
$64.39B
11.47
-2.37%
13 Buy
11 Hold
0 Sell
Moderate Buy
$1.305 (7.5%)
$59.69B
13.42
+9.44%
8 Buy
1 Hold
0 Sell
Strong Buy
$2.833 (6.95%)
$8.56B
15.13
+13.54%
3 Buy
2 Hold
0 Sell
Moderate Buy
$1.92 (8.54%)
$15.83B
10.99
+9.33%
10 Buy
2 Hold
0 Sell
Strong Buy

FAQ

How much is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H's dividend?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) does not pay a dividend
When is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ex-dividend date?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) does not pay a dividend.
When is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H dividend payment date?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) does not pay a dividend.
Does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H have sufficient earnings to cover their dividend?
The Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has paid a dividend in the last year and may provide dividends in the near future.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis